ATC Group: V04CX05 13C-urea

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V04CX05 in the ATC hierarchy

Level Code Title
1 V Various
2 V04 Diagnostic agents
3 V04C Other diagnostic agents
4 V04CX Other diagnostic agents
5 V04CX05

Active ingredients in V04CX05

Active Ingredient Description
Urea ยนยณC

13C-urea is administered in the course of the breath test. After oral ingestion the labelled urea reaches the gastric mucosa. In the presence of Helicobacter pylori the 13C-urea is metabolised by the enzyme urease of Helicobacter pylori.

Related product monographs

Title Information Source Document Type  
DIABACT UBT Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Singapore (SG)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.